More on AGIO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $37.19 |
|
|||
| Open | $36.93 | ||||
| 52 Wk High | $71.49 | ||||
| 52 Wk Low | $33.50 | ||||
| Day High | $37.32 | ||||
| Day Low | $36.10 | ||||
| P/E | N/A | ||||
| EPS | $-1.18 | ||||
| Volume | 920,052 | ||||
- Form 4 AGIOS PHARMACEUTICALS, For: Oct 21 Filed by: Gheuens Sarah
- Form 144 AGIOS PHARMACEUTICALS, Filed by: Gheuens Sarah
- Form 144 AGIOS PHARMACEUTICALS, Filed by: Gheuens Sarah
- Agios Pharma (AGIO) Reiterated at Overweight by Cantor Fitzgerald as PDUFA Date Approaches
- Agios to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5 at 8:00 a.m. ET
- Agios Pharma (AGIO) PT Lowered to $37 at Truist Securities
- TD Cowen Assumes Agios Pharma (AGIO) at Buy
- Agios Pharma (AGIO) Reiterated at Overweight by Cantor Fitzgerald on Thalassemia Opportunity
- Agios Pharma (AGIO) PT Raised to $34 at JPMorgan
- Form 4 AGIOS PHARMACEUTICALS, For: Aug 04 Filed by: Gheuens Sarah
Entities mentioned with AGIO
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- PDUFA | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
